Commercialization Partners

Adamas targets large market opportunities where combination therapy offers significant advantages over monotherapy. The Company's focus is on versatile chemical classes that can be combined and optimized to achieve the improved PK profiles, strengths and controlled release that are characteristic of Adamas' proprietary, highly differentiated Advantaged Therapeutics.

Adamas is currently seeking marketing partners for co-development collaborations.

Peter Hadrovic
SVP, Corporate Development
phadrovic@adamaspharma.com
510-450-3544